verona pharma merck - Search News

News

Merck shells out $10 billion for Verona

The Wall Street Journal on MSN · 4d

Merck to Buy Verona Pharma in $10 Billion Deal

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Reuters on MSN · 3d

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

MarketWatch on MSN · 4d

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s Ohtuvayre.

2d

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

1d

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...

4don MSN

Merck spends $10 billion for Verona, gaining access to its COPD medication

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

4don MSN

Merck nears about $10 billion deal for London-based lung therapy firm Verona, FT reports

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results